The global in vitro fertilization market is projected to reach USD 1.65 billion by 2029 from USD 949 million in 2024, growing at a CAGR of 11.7% during the forecast period. The projected market growth for in vitro fertilization is supported by the convergence of benefits. In Vitro Fertilization convergence of advantages supports the projected market growth of this industry. In vitro fertilization: A host of factors drives the demand, from improvements in assisted reproductive technologies improving treatment efficacy to expanded fertility service coverage by healthcare and availability of specialized clinics with highly qualified professionals specialized in health reproduction issues. The restraints are the high cost of the procedure that may put treatment beyond the reach of too many people or even couples.
By speeding up the problems of infertility, increasing IVF procedures for early detection of possible complications, and introducing continuous advanced technologies.
Asia Pacific to register highest growth rate in the market during the forecast period.
The highest CAGR is likely to be registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific is made up of India, China, Japan, South Korea, Australia, and RoAPAC. The Asia-Pacific region has reflected the highest upsurge in the market growth rate for in vitro fertilization.
The majority of the share of in vitro fertilization (IVF) markets in the Asia-Pacific are top for a number of indispensable reasons With a number of important considerations countries in the Asia Pacific region now own the highest share of the in vitro fertilization market. First and foremost, IVF service needs have increased due to rising rates of infertility, commonality in delayed childbearing, and changes in lifestyle. Better infrastructural facilities in healthcare, rising disposable incomes, and increasing awareness about fertility treatments are making more countries across this region accept and procure IVF. Added to these is the development of reproductive technologies and government programs encouraging fertility treatments, which support the growth of the Asia Pacific industry.
IVF EquipmentsS to register largest market share in 2022-2029.
The kinds of equipment that are essential to dispensation of IVF treatment and their development for its success. In a nutshell, IVF mainly relies upon specialized tools such as embryo culture incubators, micromanipulators used for ICSI, and the cryopreservation systems used in the storage of embryos and gametes. Advanced imaging technologies allow for time-lapse imaging in the selection of viable embryos, and next-generation sequencing tools in the field of genetic screening improve embryo quality assessment. Together with advances in medical technology, IVF equipment is undergoing innovation. Such innovative research is institutionalized and underpinned by larger industrial initiatives that continue to drive success rates and overall patient outcomes. From the regulatory standards ensuring safety and effectiveness, to the healthcare policies increasing coverage for infertility treatments, and the highest role in making IVF equipment available worldwide, these combine to drive technological evolution and put the newest innovations in reproductive solutions before more and more people in need of fertility assistance.Fertility Clinics & IVF Centres segment held the largest share of in vitro fertilization market in 2023, by End-user.
Based on the end-user, the in vitro fertilization market is segmented into fertility clinics & IVF centres, hospitals, surgical centers, and cryobanks. In the year 2023, the global in vitro fertilization market was dominated by hospitals and clinics. The growth of the hospital & clinic segment is getting accelerated.By speeding up the problems of infertility, increasing IVF procedures for early detection of possible complications, and introducing continuous advanced technologies.
Fresh non donor to register highest growth rate in the market during the forecast period.
By Cycle Fresh Donor, Frozen Donor, Frozen Non Donor, Fresh Non Donor. Fresh non-donor is likely to grow at the fastest rate in the period from 2024-2029. Geographically On the basis of several leading and niche products, the market has been expounded,, and. with All the Reason the Market Seeing So Many Inexperienced Joiners without a Donor Vehicle. Whereas before, high entry barriers were powered by technologies and broad availability, which let people get involved in these app-based schemes without experience or donor vehicles.Asia Pacific to register highest growth rate in the market during the forecast period.
The highest CAGR is likely to be registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific is made up of India, China, Japan, South Korea, Australia, and RoAPAC. The Asia-Pacific region has reflected the highest upsurge in the market growth rate for in vitro fertilization.
The majority of the share of in vitro fertilization (IVF) markets in the Asia-Pacific are top for a number of indispensable reasons With a number of important considerations countries in the Asia Pacific region now own the highest share of the in vitro fertilization market. First and foremost, IVF service needs have increased due to rising rates of infertility, commonality in delayed childbearing, and changes in lifestyle. Better infrastructural facilities in healthcare, rising disposable incomes, and increasing awareness about fertility treatments are making more countries across this region accept and procure IVF. Added to these is the development of reproductive technologies and government programs encouraging fertility treatments, which support the growth of the Asia Pacific industry.
A number of drivers were responsible for the upswing, including:
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 - 30%, Tier 2 - 42%, and Tier 3 - 28%
- By Designation: C-level- - 10%, Director-level - 14%, and Others - 76%
- By Region: North America - 40%, Europe - 30%, Asia Pacific - 22%, Rest of the world - 8%
Research Coverage
The segmentation is based on products, cycle, procedure, end user, and region. The report analyzes the factors that have been affecting and will affect the growth of the market, including drivers, restraints, opportunities, and challenges. The report details opportunities and challenges in the in vitro fertilization market for stakeholders. Further details on competitive landscapes for market leaders are also provided. This report evaluates micro-markets with respect to the growth trends, prospects, and contributions towards the global in vitro fertilization market. The report expects the revenues of the segments of the market to increase with a view of five major regions.Key Benefits of Buying the Report:
- The report intends to help new entrants, it addresses the availability of comprehensive data to help new entrants, top players of the in vitro fertilization market, and small enterprises understand investment viability. It shall aid processes of robust risk assessment and which investment decisions. It offers precise segmentation of markets, like that based on end-users and regional dimensions, hence giving targeted segments tailored insights. It also evaluates the highest trends, challenges, growth drivers, and opportunities for the same, thereby empowering strategic decision-making with insightful judgment.
The report provides the insights on the following pointers:
Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the in vitro fertilization market: Advanced technology and ageing population of women; high cost of IVF procedures and ethical concerns; growing number of fertility clinics and increased treatment option.They have declined infertility treatment among women of high age.- Product Development/Innovation: Insights into pipeline technologies, research & development activities, and new product & service launches in the in vitro fertilization market.
Market Development: Detailed information about lucrative markets - the report analyses the in vitro fertilization market across varied regions.
Market Diversification: Detailed insight into new products, untapped geographies, recent developments, and investments in the in vitro fertilization market.
- Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as CooperSurgical Inc.(US), Vitrolife (Sweden), Cook Medical Inc.(US), Hamilton Thorne (US) and Thermo Fisher Scientific(US) among others.
Table of Contents
1 Introduction
2 Research Methodology
4 Premium Insights
5 Market Overview
6 in Vitro Fertilization Market, by Product
7 in Vitro Fertilization Market, by Type of Cycle
8 in Vitro Fertilization Market, by Procedure
9 in Vitro Fertilization Market, by End-user
10 in Vitro Fertilization Market, by Region
11 Competitive Landscape
12 Company Profiles
13 Appendix
List of Tables
List of Figures
Companies Mentioned
- Coopersurgical, Inc.
- Vitrolife
- Cook Medical Inc.
- Hamilton Thorne
- Thermo Fisher Scientific Inc.
- Fujifilm Irvine Scientific
- Kitazato Corporation
- Esco Micro Pte. Ltd.
- Fertipro Nv
- Genea Biomedx
- Nikon Corporation
- Olympus
- Corning Incorporated
- Carl Zeiss Microscopy GmbH
- Eppendorf
- Meiji Techno
- Leica Microsystems
- GE Healthcare
- Bioimager
- Allwin Medical Devices
- Shanghai Unicorn Medical Technology
- Gynemed
- Invitrocare
- Ivftech
- Labivf
- Monash Biotech
- Hunter Scientific
- Calibre Scientific
- Shivani Scientific Industries (P) Ltd.
- Minitube Human Art
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 281 |
Published | August 2024 |
Forecast Period | 2024 - 2029 |
Estimated Market Value ( USD | $ 949 Million |
Forecasted Market Value ( USD | $ 1650 Million |
Compound Annual Growth Rate | 11.7% |
Regions Covered | Global |
No. of Companies Mentioned | 30 |